| pubmed-article:45724 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0025920 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0858252 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C2348767 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0058725 | lld:lifeskim |
| pubmed-article:45724 | lifeskim:mentions | umls-concept:C0085752 | lld:lifeskim |
| pubmed-article:45724 | pubmed:issue | 4-5 | lld:pubmed |
| pubmed-article:45724 | pubmed:dateCreated | 1994-6-9 | lld:pubmed |
| pubmed-article:45724 | pubmed:abstractText | Tissue analyses and tumour regression studies using the oncolytic antibiotic, adriamycin (14-hydroxydaunomycin), and its DNA complex at adriamycin dosages of 5 mg/kg and 10 mg/kg were made on C3H mice with transplanted mammary adenocarcinoma. Chemical analysis indicated a significantly lower (P < 0.05) uptake of adriamycin into cardiac tissue for the adriamycin-DNA complex. Tumour regression was comparable for both the complex and free adriamycin. Results suggest an advantageous role for the adriamycin DNA complex in the chemotherapy of metastatic breast carcinoma. | lld:pubmed |
| pubmed-article:45724 | pubmed:language | eng | lld:pubmed |
| pubmed-article:45724 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:45724 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:45724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:45724 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:45724 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:45724 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:45724 | pubmed:issn | 0304-3835 | lld:pubmed |
| pubmed-article:45724 | pubmed:author | pubmed-author:BrownII | lld:pubmed |
| pubmed-article:45724 | pubmed:author | pubmed-author:WardH WHW | lld:pubmed |
| pubmed-article:45724 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:45724 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:45724 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:45724 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:45724 | pubmed:pagination | 227-32 | lld:pubmed |
| pubmed-article:45724 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-An... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Mi... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-My... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-In... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Fe... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-DN... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Ad... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Ne... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Ma... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Ti... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Mi... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Th... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-Do... | lld:pubmed |
| pubmed-article:45724 | pubmed:meshHeading | pubmed-meshheading:45724-DN... | lld:pubmed |
| pubmed-article:45724 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:45724 | pubmed:articleTitle | The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma. | lld:pubmed |
| pubmed-article:45724 | pubmed:affiliation | Department of Radiotherapy and Clinical Oncology, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, U.K. | lld:pubmed |
| pubmed-article:45724 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:45724 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:45724 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
